Cover Image
市場調查報告書

轉染試劑、設備的全球市場分析、預測 (∼2020年):各手法 (生物化學性手法、物理性手法、病毒性手法)、用途

Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 334121
出版日期 內容資訊 英文 195 Pages
訂單完成後即時交付
價格
Back to Top
轉染試劑、設備的全球市場分析、預測 (∼2020年):各手法 (生物化學性手法、物理性手法、病毒性手法)、用途 Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020
出版日期: 2015年07月01日 內容資訊: 英文 195 Pages
簡介

為了滿足來自研究人員和生物科技、生物醫藥企業的必要條件,轉染試劑、設備的市場上過去數年來實現了許多的技術進步。這些進步導致高效率性的轉染設備開發,實現各種細胞的效率性且高品質的轉染。

本報告提供全球轉染試劑、設備的市場相關調查、試劑、設備種類與概要、對市場成長的各種影響因素及市場機會分析、產品、手法的市場分析及市場成長預測、各地區的趨勢、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 全球轉染技術市場
  • 各用途、地區市場
  • 各產品市場

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 成長推進因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 轉染技術市場:各產品

  • 簡介
  • 試劑
  • 設備、器具

第7章 轉染技術市場:各手法

  • 簡介
  • 生物化學的手法
    • 磷酸鈣
      • 優點
      • 缺點
    • 脂轉染
      • 優點
      • 缺點
    • DEAE-聚葡萄糖
      • 優點
      • 缺點
    • 樹狀聚合物
      • 優點
      • 缺點
  • 物理性手法
    • 簡介
    • 電穿孔
      • 優點
      • 缺點
    • 細胞核轉染
      • 優點
      • 缺點
    • 其他
      • Sonoporation
        • 優點
        • 缺點
      • 遺傳基因槍
        • 優點
        • 缺點
      • Magnetofection
        • 優點
        • 缺點
      • Optoinjection
        • 優點
        • 缺點
    • 病毒的手法
      • 簡介
      • 優點
      • 規定

第8章 轉染技術市場:各用途

  • 簡介
  • 生物醫學的研究
    • 基因表現的研究
    • 癌症研究
    • 基因轉殖模式
  • 蛋白質生成
  • 藥物輸送

第9章 全球轉染技術市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 太平洋各國
    • 其他
  • 其他
    • 南美
    • 中東、非洲

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
  • 協定、合作、策略性聯盟
  • 新產品的投入
  • 擴張
  • 收購
  • 其他

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC. (LIFE TECHNOLOGIES)
  • PROMEGA CORPORATION
  • QIAGEN N.V.
  • POLYPLUS TRANSFECTION SA
  • ROCHE
  • BIO-RAD LABORATORIES INC.
  • LONZA GROUP
  • SIGMA- ALDRICH CORPORATION
  • MIRUS BIO LLC.
  • MAXCYTE, INC.
    • 產業概要
    • 財務資訊
    • 產品與服務
    • 策略
    • 發展趨勢等

第12章 附錄

圖表

目錄
Product Code: BT 3562

Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology and biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.

In 2015, the reagents segment is expected to account for the largest share of the transfection reagents and equipment market, by product; the biochemical method segment is expected to account for the largest share of the global transfection reagents and equipment market, by method; while the biomedical research segment is expected to account for the largest share of the transfection reagents and equipment market, by application.

In 2015, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and rest of the world (RoW). In future, the transfection reagents and equipment market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. High growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidences, and favorable regulatory framework.

The global transfection reagents and equipment market witnesses' low competitive intensity as Thermo Fisher Scientific, Inc. (U.S.) occupies majority of the market share. However, several other players and many small firms with similar product offerings are adopting various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, and application
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • 4.2. TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION AND REGION
  • 4.3. TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing Research Activities In Cell Science
      • 5.3.1.2. Technological Advancements In Transfection Instruments And Reagents
      • 5.3.1.3. Rising Incidence of Cancer Worldwide
      • 5.3.1.4. Global Alliances Among Leading Research Institutes to Trigger Drug Discovery
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High Reliability on Grants Might Restrict Growth
      • 5.3.2.2. Selective Effectiveness of Transfection Reagents
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Large-Scale Transfections likely to propel Transfection Equipment market
      • 5.3.3.2. Rising Demand for Protein Therapeutics
      • 5.3.3.3. Asian Market Presents High-Growth Opportunities
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Transfection in hard-to-transfect cells

6. TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. REAGENTS
  • 6.3. EQUIPMENT/INSTRUMENTS

7. TRANSFECTION TECHNOLOGIES MARKET, BY METHOD

  • 7.1. INTRODUCTION
  • 7.2. BIOCHEMICAL METHODS
    • 7.2.1. CALCIUM PHOSPHATE
      • 7.2.1.1. Advantages
      • 7.2.1.2. Disadvantages
    • 7.2.2. LIPOFECTION
      • 7.2.2.1. Advantages
      • 7.2.2.2. Disadvantages
    • 7.2.3. DEAE-DEXTRAN
      • 7.2.3.1. Advantages
      • 7.2.3.2. Disadvantages
    • 7.2.4. DENDRIMERS
      • 7.2.4.1. Advantages
      • 7.2.4.2. Disadvantages
  • 7.3. PHYSICAL
    • 7.3.1. INTRODUCTION
    • 7.3.2. ELECTROPORATION
      • 7.3.2.1. Advantages
      • 7.3.2.2. Disadvantages
    • 7.3.3. NUCLEOFECTION
      • 7.3.3.1. Advantages
      • 7.3.3.2. Disadvantages
    • 7.3.4. OTHER METHODS
      • 7.3.4.1. Sonoporation
      • 7.3.4.2. Gene Gun
        • 7.3.4.2.1. Advantages
        • 7.3.4.2.2. Disadvantages
      • 7.3.4.3. Magnetofection
        • 7.3.4.3.1. Advantages
        • 7.3.4.3.2. Disadvantages
      • 7.3.4.4. Optoinjection
        • 7.3.4.4.1. Advantages
        • 7.3.4.4.2. Disadvantages
    • 7.4. VIRAL METHODS
      • 7.4.1. INTRODUCTION
      • 7.4.2. ADVANTAGES
      • 7.4.3. LIMITATIONS

    8. TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION

    • 8.1. INTRODUCTION
    • 8.2. BIOMEDICAL RESEARCH
      • 8.2.1. GENE EXPRESSION STUDIES
      • 8.2.2. CANCER RESEARCH
      • 8.2.3. TRANSGENIC MODELS
    • 8.3. PROTEIN PRODUCTION
    • 8.4. THERAPEUTIC DELIVERY

    9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET, BY REGION

    • 9.1. INTRODUCTION
    • 9.2. NORTH AMERICA
      • 9.2.1. U.S.
        • 9.2.1.1. Increase in Bio-Based Drug Research
        • 9.2.1.2. Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market
        • 9.2.1.3. Growing Funding for Biotechnology and for Development of Protein Based Biologics
    • 9.2.2. CANADA
      • 9.2.2.1. Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies
      • 9.2.2.2. Increasing Investments by the Canadian Government on Regenerative Medicine to Spur Market Growth
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Advances in the Biotechnological & Research Sectors
      • 9.3.1.2. Collaboration Among the Bio-Pharmaceutical and Biotechnology Companies for Development of New Vaccines is Likely the Spur the Market Growth
    • 9.3.2. U.K.
      • 9.3.2.1. Strong Biotechnology Industry
      • 9.3.2.2. Increase in R&D Investments
    • 9.3.3. FRANCE
      • 9.3.3.1. Strong Biotechnology Industry in France
    • 9.3.4. REST OF EUROPE (ROE)
      • 9.3.4.1. Growing Biotechnology Industry in Italy and Spain
      • 9.3.4.2. Investments and Funding for Life Sciences to Bolster the Transfection Technologies Market
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
      • 9.4.1.1. Rise in Biomedical Research in Japan
    • 9.4.2. CHINA
      • 9.4.2.1. Increasing Government and Private Sector Investments in China's Life Sciences Market
    • 9.4.3. INDIA
      • 9.4.3.1. Booming Pharmaceutical Industry and Funding for Biotechnology
      • 9.4.3.2. Development of Bio-Clusters in India
    • 9.4.4. PACIFIC COUNTRIES
      • 9.4.4.1. Favourable Regulatory Changes to Increase the Market in New Zealand and Australia
      • 9.4.4.2. Federal Collaborations in Australia
    • 9.4.5. REST OF ASIA-PACIFIC
      • 9.4.5.1. Rising Pharmaceutical and Biotechnology R&D Activities in Korea
      • 9.4.5.2. Government Support for Strong Academic and Commercial R&D Activities in Taiwan
  • 9.5. REST OF THE WORD (ROW)
    • 9.5.1. LATIN AMERICA
      • 9.5.1.1. Increasing Investment in Brazil and Mexico
    • 9.5.2. MIDDLE EAST AND AFRICA
      • 9.5.2.1. Increasing Focus of Major Pharmaceutical, Biopharmaceutical and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS, TRANSFECTION TECHNOLOGIES MARKET (2014)
  • 10.3. COMPETITIVE SITUATION AND TRENDS
  • 10.4. AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & STRATEGIC ALLIANCES
  • 10.5. NEW PRODUCT LAUNCHES
  • 10.6. EXPANSIONS
  • 10.7. ACQUISITIONS
  • 10.8. OTHERS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. INTRODUCTION
  • 11.2. THERMO FISHER SCIENTIFIC, INC. (LIFE TECHNOLOGIES)
  • 11.3. PROMEGA CORPORATION
  • 11.4. QIAGEN N.V.
  • 11.5. POLYPLUS TRANSFECTION SA
  • 11.6. ROCHE
  • 11.7. BIO-RAD LABORATORIES INC.
  • 11.8. LONZA GROUP
  • 11.9. SIGMA- ALDRICH CORPORATION
  • 11.10. MIRUS BIO LLC.
  • 11.11. MAXCYTE, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2012-2015)
    • 12.2.1. THERMO FISHER SCIENTIFIC, INC.
    • 12.2.2. PROMEGA CORPORATION
    • 12.2.3. QIAGEN N.V.
    • 12.2.4. SIGMA-ALDRICH CORPORATION
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCREASING RESEARCH ACTIVITIES IN CELL SCIENCE PROPELLING GROWTH OF THE GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • TABLE 2: HIGH RELIABILITY ON RESEARCH GRANTS AND LACK OF EFFICIENCY OF TRANSFECTION REAGENTS RESTRICTING THE GROWTH OF THE GLOBAL TRANSFECTION TECHNOLOGIES MARKET
  • TABLE 3: LARGE SCALE TRANSFECTION AND RISING DEMAND OF PROTEIN THERAPEUTICS INFLUENCE THE GROWTH OF THE TRANSFECTION TECHNOLOGIES MARKET
  • TABLE 4: TRANSFECTION IN HARD-TO-TRANSFECT CELL POSE AS A CHALLENGE IN THE GROWTH OF THE TRANSFECTION TECHNOLOGIES MARKET
  • TABLE 5: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 6: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR REAGENTS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 7: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR EQUIPMENT, BY REGION, 2013-2020 ($MILLION)
  • TABLE 8: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 9: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 10: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 11: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 12: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR LIPOFECTION METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 13: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR DEAE-DEXTRAN METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 14: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR DENDRIMER METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 15: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 16: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY REGION, 2013-2020 ($MILLION)
  • TABLE 17: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ELECTROPORATION, BY REGION, 2013-2020 ($MILLION)
  • TABLE 18: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR NUCLEOFECTION, BY REGION, 2013-2020 ($MILLION)
  • TABLE 19: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR OTHER PHYSICAL METHODS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 20: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR VIRAL METHODS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 21: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 22: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 23: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY REGION, 2013-2020 ($MILLION)
  • TABLE 24: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2013-2020 ($MILLION)
  • TABLE 25: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH, BY REGION, 2013-2020 ($MILLION)
  • TABLE 26: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS, BY REGION, 2013-2020 ($MILLION)
  • TABLE 27: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION, BY REGION, 2013-2020 ($MILLION)
  • TABLE 28: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY, BY REGION, 2013-2020 ($MILLION)
  • TABLE 29: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 30: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 31: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020($MILLION)
  • TABLE 32: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 33: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 34: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 35: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 36: NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 37: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 38: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 39: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 40: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 41: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 42: U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 43: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 44: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 45: CANADA : TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 46: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 47: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 48: CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 49: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 50: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 51: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 52: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 53: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 54: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 55: EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 56: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 57: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 58: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 59: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 60: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 61: GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 62: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 63: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 64: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE 2013-2020 ($MILLION)
  • TABLE 65: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE 2013-2020 ($MILLION)
  • TABLE 66: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 67: U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 68: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 69: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 70: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 71: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 72: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 73: FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 74: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 75: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 76: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 77: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 78: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 79: ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 80: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 81: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 82: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 83: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 84: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 85: ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 86: APAC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 87: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 88: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 89: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 90: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 91: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 92: JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 93: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 94: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 95: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 96: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 97: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 98: CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 99: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 100: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 101: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 102: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 103: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 104: INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 105: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 106: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 107: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 108: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 109: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 110: PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH , BY TYPE, 2013-2020 ($MILLION)
  • TABLE 111: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 112: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2013-2020 ($MILLION)
  • TABLE 113: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 114: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 115: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 116: REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 117: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 118: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHODS, 2013-2020 ($MILLION)
  • TABLE 119: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 120: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 121: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 122: ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 123: AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012-2015
  • TABLE 124: NEW PRODUCT LAUNCHES 2012-2015
  • TABLE 125: EXPANSIONS 2012-2015
  • TABLE 126: ACQUISITIONS 2012-2015
  • TABLE 127: OTHER STRATEGIES 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL TRANSFECTION TECHNOLOGIES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: VIRAL TRANSFECTION METHOD MARKET TO WITNESS THE HIGHEST CAGR FROM 2015 TO 2020
  • FIGURE 9: REAGENTS COMMAND THE LARGEST MARKET SHARE IN 2015
  • FIGURE 10: THE BIOMEDICAL RESEARCH APPLICATION SEGMENT IS EXPECTED TO CONTINUE TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: ASIA IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: INCREASED CELL BASED RESEARCH ACTIVITIES TO DRIVE THE MARKET GROWTH
  • FIGURE 13: NORTH AMERICA DOMINATED THE TRANSFECTION TECHNOLOGIES MARKET IN 2015
  • FIGURE 14: APAC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: REAGENTS CONTINUE TO DOMINATE THE MARKET S
  • FIGURE 16: TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 17: DRIVERS, RESTRAINTS, CHALLENGES & OPPORTUNITIES
  • FIGURE 18: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD
  • FIGURE 19: TRANSFECTION TECHNOLOGIES MARKET : BY APPLICATION
  • FIGURE 20: TRANSFECTION TECHNOLOGIES MARKET : BY REGION
  • FIGURE 21: NORTH AMERICA TRANSFECTION TECHNOLOGIES MARKET : U.S. COMMANDS THE LARGEST SHARE
  • FIGURE 22: EUROPE TRANSFECTION TECHNOLOGIES MARKET : GERMANY COMMANDS THE LARGEST SHARE
  • FIGURE 23: APAC TRANSFECTION TECHNOLOGIES MARKET : JAPAN COMMANDS THE LARGEST SHARE
  • FIGURE 24: COLLABORATIONS/AGREEMENTS/PARTNERSHIPS/ALLIANCES WAS THE KEY GROWTH STRATEGY FOR MARKET PLAYERS
  • FIGURE 25: GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 26: BATTLE FOR MARKET SHARE: COLLABORATIONS/AGREEMENTS/ PARTNERSHIPS/ALLIANCES WAS THE KEY STRATEGY
  • FIGURE 27: KEY PLAYERS FOCUSING ON AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012-2015
  • FIGURE 28: KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2012-2015
  • FIGURE 29: KEY PLAYERS FOCUSING ON EXPANSIONS, 2012-2015
  • FIGURE 30: KEY PLAYERS FOCUSING ON ACQUISITIONS, 2012-2015
  • FIGURE 31: KEY PLAYERS FOCUSING ON OTHER STRATEGIES, 2012-2015
  • FIGURE 32: GEOGRAPHIC REVENUE MIX OF TOP 4 MARKET PLAYERS
  • FIGURE 33: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 34: PROMEGA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 35: QIAGEN N.V. : COMPANY SNAPSHOT
  • FIGURE 36: ROCHE: COMPANY SNAPSHOT
  • FIGURE 37: BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 38: LONZA GROUP: COMPANY SNAPSHOT
  • FIGURE 39: SIGMA-ALDRICH CORPORATION : COMPANY SNAPSHOT
Back to Top